We are live on ! Find out more
PACB icon

Pacific Biosciences
PACB

80 hedge funds and large institutions have $197M invested in Pacific Biosciences in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 27

7% more capital invested

Capital invested by funds: $184M → $197M (+$13.1M)

5% less call options, than puts

Call options by funds: $223K | Put options by funds: $234K

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

1% less funds holding

Funds holding: 81 → 80 (-1)

Holders
80
Holders Change
-1
Holders Change %
-1.23%
% of All Funds
2.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
36
Reduced
27
Closed
12
Calls
$223K
Puts
$234K
Net Calls
-$11K
Net Calls Change
-$313K

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$8.36M
2
BA
BlackRock Advisors
Delaware
+$6.51M
3
MC
Maverick Capital
Texas
+$2.96M
4
OIM
Oracle Investment Management
Connecticut
+$2.82M
5
BIM
Bogle Investment Management
Massachusetts
+$2.59M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$8.71M
2
DM
Deerfield Management
New York
-$2.45M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.55M
4
EI
EAM Investors
California
-$1.12M
5
RFC
Russell Frank Company
Washington
-$967K
Name Holding Trade Value Shares
Change 		Change in
Stake
MC
1
Maverick Capital
Texas
$33.8M +$2.96M +645,065 +11%
DM
2
Deerfield Management
New York
$22.8M -$2.45M -533,106 -11%
OIM
3
Oracle Investment Management
Connecticut
$13.5M +$2.82M +614,041 +31%
BIT
4
BlackRock Institutional Trust
California
$12.8M +$8.36M +1,821,803 +288%
Millennium Management
5
Millennium Management
New York
$12.8M +$1.53M +332,713 +16%
Blackstone Inc
6
Blackstone Inc
New York
$12.6M – – –
BA
7
BlackRock Advisors
Delaware
$11.1M +$6.51M +1,416,914 +200%
BFA
8
BlackRock Fund Advisors
California
$10.9M +$56K +12,196 +0.6%
RCM
9
Raging Capital Management
New Jersey
$6.6M +$1.16M +252,200 +25%
Vanguard Group
10
Vanguard Group
Pennsylvania
$5.24M +$980K +213,476 +27%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$4.33M +$660K +143,828 +21%
BIM
12
Bogle Investment Management
Massachusetts
$3.61M +$2.59M +564,772 +450%
Invesco
13
Invesco
Georgia
$3.41M +$2.3M +500,900 +331%
Northern Trust
14
Northern Trust
Illinois
$3.35M +$116K +25,252 +4%
State Street
15
State Street
Massachusetts
$3.33M +$412K +89,710 +16%
Fuller & Thaler Asset Management
16
Fuller & Thaler Asset Management
California
$3.24M -$73K -15,900 -3%
PAM
17
Panagora Asset Management
Massachusetts
$2.9M +$74.7K +16,272 +3%
California Public Employees Retirement System
18
California Public Employees Retirement System
California
$2.56M -$6.43K -1,400 -0.3%
TC
19
TFS Capital
Pennsylvania
$1.97M -$832K -181,224 -33%
Morgan Stanley
20
Morgan Stanley
New York
$1.52M +$973K +211,936 +272%
IG
21
ING Group
Netherlands
$1.31M +$1.15M +250,000 New
BCM
22
Bridgeway Capital Management
Texas
$1.3M -$130K -28,400 -10%
TCIM
23
TIAA CREF Investment Management
New York
$1.25M +$112K +24,300 +11%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$1.22M +$74K +16,113 +7%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$1.22M +$60.9K +13,258 +6%
1
2 3 4

PACB Hedge Fund Activity: Q4 2013 in Review

80 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q4 2013, worth a combined $197M — up 7.2% from $184M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of PACB and 11 opened new positions — a net loss of 1 holder — while 27 trimmed existing stakes and 36 added.

The largest buyer was BlackRock Institutional Trust, adding an estimated $8.36M. The largest seller was Redmile Group, exiting entirely with an estimated $8.71M sold.

  • 80 institutional investors held Pacific Biosciences (PACB) as of Q4 2013, down from 81 in Q3 2013.
  • Funds reported $197M of Pacific Biosciences stock for Q4 2013, up 7.2% quarter-over-quarter.
  • 11 funds opened new Pacific Biosciences positions in Q4 2013 and 12 closed out, a net change of -1 holder.
  • The largest Pacific Biosciences buyer in Q4 2013 was BlackRock Institutional Trust, an estimated $8.36M added.
  • The largest Pacific Biosciences seller in Q4 2013 was Redmile Group, an estimated $8.71M sold.

Based on aggregated 13F filings for Q4 2013.